about
Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurementsA comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determinationDoes activation of the FcgammaRIIa play a role in the pathogenesis of the acute lung injury/acute respiratory distress syndrome?Photocleavable peptide-conjugated magnetic beads for protein kinase assays by MALDI-TOF MSCharacterization of ERK docking domain inhibitors that induce apoptosis by targeting Rsk-1 and caspase-9.Chemical screens against a reconstituted multiprotein complex: myricetin blocks DnaJ regulation of DnaK through an allosteric mechanismViewing serine/threonine protein phosphatases through the eyes of drug designersAssessment of tumor response to tyrosine kinase inhibitorsPharmacological Inhibition of Protein Kinase G1 Enhances Bone Formation by Human Skeletal Stem Cells Through Activation of RhoA-Akt Signaling.Pooled screening for antiproliferative inhibitors of protein-protein interactions.Multiplexed visualization of dynamic signaling networks using genetically encoded fluorescent protein-based biosensorsTargeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin.Receptor tyrosine kinase inhibitors in rodent pulmonary hypertension.cAMP-dependent protein kinase from Plasmodium falciparum: an update.Role of tyrosine kinase inhibitors in tumor immunology.Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy.Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases.c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Design and synthesis of novel protein kinase R (PKR) inhibitors.Identification of inhibitors of the Leishmania cdc2-related protein kinase CRK3.Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.Identification of novel kinase inhibitors by targeting a kinase-related apoptotic protein-protein interaction network in HeLa cells.Kinase inhibition by deoxy analogues of the resorcylic lactone L-783277.Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.Quantitative chemical proteomics identifies novel targets of the anti-cancer multi-kinase inhibitor E-3810.Comparison of luminescence ADP production assay and radiometric scintillation proximity assay for Cdc7 kinase.Screening and identification of small molecule inhibitors of ErbB2-induced invasion.Peptide-Modulated Activity Enhancement of Acidic Protease Cathepsin E at Neutral pH.Chemical shift assignments of the partially deuterated Fyn SH2-SH3 domain.Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease.Protein kinase inhibitors for acute leukemia.Tracking anti-fibrotic pathways of nilotinib and imatinib in experimentally induced liver fibrosis: an insight.A new terpene coumarin microbial transformed by Mucor polymorphosporus induces apoptosis of human gastric cancer cell line MGC-803.Apoptosis Reversal Promotes Cancer Stem Cell-Like Cell Formation.Conservation of structural fluctuations in homologous protein kinases and its implications on functional sites.Highly efficient and selective phosphorylation of amino acid derivatives and polyols catalysed by 2-aryl-4-(dimethylamino)pyridine-N-oxides--towards kinase-like reactivity.Computer simulation based selection of optimal monomer for imprinting of tri-O-acetiladenosine in polymer matrix: vacuum calculations.Quantitative proteomic characterization and comparison of T helper 17 and induced regulatory T cells.Metal Compounds as Kinase and Phosphatase Inhibitors in Drug Development: The Role of the Metal and Ligands
P2860
Q28475132-9FAC5B09-C52B-4B25-BAD0-C222C4BA4BC0Q28539535-3E8C4808-5F90-4A4A-B1D1-777931D92734Q33610593-186A7C35-8BAA-4DC0-8B9E-9D739D0BA5ECQ33699182-30152956-A358-4CCB-883A-99B7A275DDEDQ33789572-94F09AA3-3CA8-4CDF-8575-146E3AE14241Q34673896-13890518-C171-432F-AADE-6A8048F7A90AQ35146774-A12C56B8-0BE6-48A9-AE53-24477EC0CBBDQ35558589-DEBEBD92-3FC0-4963-A421-BE9288ED4606Q35598732-A73D88E5-055D-4046-B4D8-3FD2AD951D3AQ35930537-BDEE1132-8624-47D6-BA39-7E49C0213249Q36644383-2EE6ADAF-3FEC-411D-88AB-2735C283633CQ37031277-CC233FDF-77DD-468B-864B-B57A98117090Q37702986-EFCC119A-DA52-4033-9422-5FA03AEE8348Q37776022-4E72E5BF-CDD6-4DE8-B66E-987E07BAE19FQ37822748-247AA5CF-291C-4479-A1E6-FDF580635E75Q37862753-716CB7C1-9A4D-45DF-994A-54AF0A38D29FQ38169198-E99D5033-68C6-4D0B-A833-DD371EEE5240Q38492604-7AF65D85-12B9-4FAA-84DB-A635C69E617DQ38835635-3FC5D89A-1397-4066-9032-0C5F79FD88FEQ38948559-B5F89C49-E9F8-42A1-92FE-D5370843D5D2Q38989374-9BF692ED-7695-40F5-A8DB-E0CB5C0DE4C3Q39227830-9A72E0F5-CEC9-496E-87A0-B7609D952193Q39510527-88462C26-4930-47E0-AEC9-9015D5A2FF17Q39652400-B0E9D6E1-A0CC-4039-AAB0-DC6262D69E84Q40373198-9743D789-A65E-4E9D-8917-C726D7DD1D37Q40374094-6059B7CA-8C42-4DAD-902F-A18EEBBECE57Q41135384-DB4F1484-4D2B-469F-9D4A-6ADB918DFB7DQ41778098-F3304E37-46E0-4570-85D8-7A8E6E3DA052Q47311466-1E4C0E6E-5202-4987-8139-A7D942C269CEQ48000590-6EE4C24A-A270-4AB6-AD12-727AD3B9427AQ49873905-80A5A70B-98E0-4DBE-A33D-FA15A9A83E7DQ50610836-40D77B14-5787-42F9-8045-07DD7B071535Q52605638-E1EAF361-40FB-4B43-B222-61F8ADA66179Q53841482-1A983432-CBE5-4D68-A7F3-37A2948A165EQ54204143-BE3A4C6F-6D6B-4E6D-AD82-F6A3DE98B2C6Q54320260-9382889A-3730-4A9D-ABEF-ABF3AF32EA66Q54487838-11D74426-EFD7-4F90-A7DE-A67B7BB47493Q55354251-1E657715-0139-4845-8C57-6245D29476FDQ57693525-1CAAE430-D038-4E62-AD0B-534E2D1FA807
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Therapeutic protein kinase inhibitors.
@ast
Therapeutic protein kinase inhibitors.
@en
Therapeutic protein kinase inhibitors.
@nl
type
label
Therapeutic protein kinase inhibitors.
@ast
Therapeutic protein kinase inhibitors.
@en
Therapeutic protein kinase inhibitors.
@nl
prefLabel
Therapeutic protein kinase inhibitors.
@ast
Therapeutic protein kinase inhibitors.
@en
Therapeutic protein kinase inhibitors.
@nl
P1476
Therapeutic protein kinase inhibitors.
@en
P2093
P2888
P304
P356
10.1007/S00018-008-8539-7
P577
2009-04-01T00:00:00Z